… In conclusion, the management of cancer appears more expensive in the older patient than
in the younger one; under specific circumstances, the addition of myelopoietic growth factors …

… of hemopoietic growth factors in older patients. … to growth factors or in response in presence
of an absolute neutrophil count lower than 1000/μL between younger and older patients. …

… suggests that the insulin-like growth factor (IGF)-axis may … growth factor-1 (IGF-I) and its
binding proteins, IGFBP-1 and IGFBP-3, with glucose intolerance and inflammation among older …

… Insulinlike growth factors (IGFs) constitute a highly conserved biological system that is
hypothesized to be a key determinant of aging and longevity. Model organisms with low IGF-1 …

… The BMI cannot distinguish adequately between fat mass and lean tissue mass, and it may
be a less useful indicator of adiposity among the older patients who have a greater amount of …

… Associations of plasma fibroblast growth factor 23 concentrations with left ventricular mass
by … Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients …

… JHI was supported by American Heart Association award 0575021N, which supported
fibroblast growth factor 23 and the other mineral metabolism measurements in this study. …

… , but much data indicates that older patients have a more … the younger patients. Approximately
60% of AML cases are in … growth factors have been studied extensively in older AML …

… Most of the effects of growth hormone are mediated by insulin-like growth factor 1 (IGF-1).
Because GH secretion is pulsatile, a more convenient marker of GH secretion is the plasma IGF…

… factor associated with frailty is required. Although serum insulin-like growth factor-1 (IGF-1)
is a potential factor … to investigate the association between IGF-1 and frailty in older adults. …